Efficacy and safety of avalglucosidase alfa in participants with late-onset Pompe disease after 145 weeks of treatment during the COMET trial
Priya S. Kishnani,Jordi Díaz-Manera,Hani Kushlaf,Shafeeq Ladha,Tahseen Mozaffar,Volker Straub,Antonio Toscano,Ans T. van der Ploeg,Paula R. Clemens,John W. Day,Sergey Illarioshkin,Mark E. Roberts,Shahram Attarian,Gerson Carvalho,Sevim Erdem-Özdamar,Ozlem Goker-Alpan,Anna Kostera-Pruszczyk,Kristina An Haack,Olivier Huynh-Ba,Swathi Tammireddy,Nathan Thibault,Tianyue Zhou,Mazen M. Dimachkie,Benedikt Schoser NEUROMUSCULAR DISORDERS(2023)
AI 理解论文
溯源树
样例